CAS
ZGNX

CTC Alternative Strategies’s Zogenix, Inc. ZGNX Stock Holding History

CTC Alternative Strategies’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,303
Closed -$45.2K – 237
2013
Q2 		$45.2K Buy
+3,303
New +$42.3K 0.01% 185

Other funds holding ZGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

CTC Alternative Strategies's ZGNX Position: Q3 2013 in Review

CTC Alternative Strategies sold out of Zogenix, Inc. (ZGNX) in Q3 2013, closing a stake of 3,303 shares — an estimated $45.2K sold.

CTC Alternative Strategies first reported a position in ZGNX in Q2 2013 and held it in 1 quarter. The position peaked at $45.2K in Q2 2013. 66 funds tracked by Wall St. Rank hold ZGNX as of Q3 2013.

  • CTC Alternative Strategies reported no remaining Zogenix, Inc. position as of Q3 2013 after selling out during the quarter.
  • CTC Alternative Strategies sold 3,303 Zogenix, Inc. shares in Q3 2013, an estimated $45.2K.
  • CTC Alternative Strategies first reported a position in Zogenix, Inc. in Q2 2013 and held it in 1 quarter.
  • CTC Alternative Strategies's Zogenix, Inc. position peaked at $45.2K in Q2 2013.
  • 66 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q3 2013.

Based on CTC Alternative Strategies's 13F filing for Q3 2013, filed 31 Oct 2013.